MALT gastric lymphomas;Les lymphomes gastriques du MALT

Revue de Medecine Interne

Volumn 25, Issue 8, 2004, Pages 573-581

  Ruskone Fourmestraux A ^a  

^a HÔTEL DIEU   (France)

Author keywords

Diagnosis; Diagnostic; Gastric lymphoma; Helicobacter pylori; l sions lympho pith liales; LG; LLE; LPGI; Lymphome gastrique; lymphome gastrique; lymphome primitif gastro intestinal; MALT; Traitement; Treatment

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; RITUXIMAB; VINCRISTINE SULFATE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER EPIDEMIOLOGY; CANCER RADIOTHERAPY; CANCER SURGERY; DIAGNOSTIC PROCEDURE; ENDOSCOPIC BIOPSY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NONHUMAN; PATHOGENESIS; PATHOLOGICAL ANATOMY; POSTOPERATIVE COMPLICATION; PROGNOSIS; SURGICAL MORTALITY; TOTAL STOMACH RESECTION;

EID: 3242758229     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.revmed.2004.02.002     Document Type: Short Survey

References (57)

1. Isaacson P.G. Mucosa-associated lymphoid tissue lymphoma. Semin Hematol. 36:1999;139-147
2. Zucca E., Cavalli F. Extranodal lymphomas. Ann Oncol. 11:(Suppl 3):2000;219-222
3. Du M.Q., Isaccson P.G. Gastric MALT lymphoma: from aetiology to treatment. Lancet Oncol. 3:2002;97-104
4. Boot H., de Jong D. Gastric lymphoma: the revolution of the past decade. Scand J Gastroenterol Suppl. 236:2002;27-36
5. Chan J.K. Gastrointestinal lymphomas: an overview with emphasis on new findings and diagnostic problems. Semin Diagn Pathol. 13:1996;260-296
6. Gurney K.A., Cartwright R.A., Gilman E.A. Descriptive epidemiology of gastrointestinal non-Hodgkin's lymphoma in a population-based registry. Br J Cancer. 79:1999;1929-1934
7. Ruskone-Fourmestraux A., Rambaud J.C. Gastrointestinal lymphoma: prevention and treatment of early lesions. Baillieres Best Pract Res Clin Gastroenterol. 15:2001;337-354
8. Zucca E., Roggero E., Maggi-Solca N., Conconi A., Bertoni F., Reilly I., et al. Prevalence of Helicobacter pylori and hepatitis C virus infections among non-Hodgkin's lymphoma patients in southern switzerland. Haematologica. 85:2000;147-153
9. Wotherspoon A.C. Gastric MALT lymphoma and Helicobacter pylori. Yale J Biol Med. 69:1996;61-68
10. Parsonnet J., Hansen S., Rodriguez L., Gelb A.B., Warnke R.A., Jellum E., et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med. 330:1994;1267-1271
11. Hussell T., Isaacson P.G., Crabtree J.E., Dogan A., Spencer J. Immunoglobulin specificity of low grade B cell gastrointestinal lymphoma of mucosa-associated lymphoid tissue (MALT) type. Am J Pathol. 142:1993;285-292
12. Du M.Q. Molecular Biology of Gastric MALT Lymphoma: Application in Clinical Management. Hematology. 7:2002;339-344
13. Isaacson P.G. The MALT lymphoma concept updated. Ann Oncol. 6:1995;319-320
14. Jaffe E.S., Harris N.L., Stein H., Vardiman J.W. World Health Organization Classification of tumours. 2001;IARC Press, Lyon
15. Isaacson P.G., Spencer J., Wright D.H. Classifying primary gut lymphomas. Lancet. 2:1988;1148-1149
16. Montalban C., Castrillo J.M., Abraira V., Serrano M., Bellas C., Piris M.A., et al. Gastric B-cell mucosa-associated lymphoid tissue (MALT) lymphoma. Clinicopathological study and evaluation of the prognostic factors in 143 patients. Ann Oncol. 6:1995;355-362
17. Ruskone-Fourmestraux A., Aegerter P., Delmer A., Brousse N., Galian A., Rambaud J.C. Primary digestive tract lymphoma: a prospective multicentric study of 91 patients. Groupe d'Etude des Lymphomes Digestifs. Gastroenterology. 105:1993;1662-1671
18. de Jong D., Boot H., Taal B. Histological grading with clinical relevance in gastric mucosa- associated lymphoid tissue (MALT) lymphoma. Recent Results Cancer Res. 156:2000;27-32
19. Kolve M.E., Fischbach W., Wilhelm M. Primary gastric non-Hodgkin's lymphoma: requirements for diagnosis and staging. Recent Results Cancer Res. 156:2000;63-68
20. Taal B.G., Boot H., van Heerde P., de Jong D., Hart A.A., Burgers J.M. Primary non-Hodgkin lymphoma of the stomach: endoscopic pattern and prognosis in low versus high grade malignancy in relation to the MALT concept. Gut. 39:1996;556-561
21. Lehours P., Ruskone-Fourmestraux A., Lavergne A., Cantet F., Megraud F. Which test to use to detect Helicobacter pylori infection in patients with low-grade gastric mucosa-associated lymphoid tissue lymphoma? Am J Gastroenterol. 98:2003;291-295
22. de Jong D., Vyth-Dreese F., Dellemijn T., Verra N., Ruskone-Fourmestraux A., Lavergne-Slove A., et al. Histological and immunological parameters to predict treatment outcome of Helicobacter pylori eradication in low-grade gastric MALT lymphoma. J Pathol. 193:2001;318-324
23. Ruskone-Fourmestraux A., Lavergne A., Aegerter P.H., Megraud F., Palazzo L., de Mascarel A., et al. Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment. Gut. 48:2001;297-303
24. Fischbach W., Dragosics B., Kolve-Goebeler M.E., Ohmann C., Greiner A., Yang Q., et al. Primary gastric B-cell lymphoma: results of a prospective multicenter study. The German-Austrian Gastrointestinal Lymphoma Study Group. Gastroenterology. 119:2000;1191-1202
25. Schechter N.R., Portlock C.S., Yahalom J. Treatment of mucosa-associated lymphoid tissue lymphoma of the stomach with radiation alone. J Clin Oncol. 16:1998;1916-1921
26. Palazzo L., Roseau G., Ruskone-Fourmestraux A., Rougier P., Chaussade S., Rambaud J.C., et al. Endoscopic ultrasonography in the local staging of primary gastric lymphoma. Endoscopy. 25:1993;502-508
27. Ruskoné-Fourmestraux A., Dragosics B., Morgner A., Wootherspoon A., de Jong D. on behalf the European Gastro-intestinal Lymphoma Study group (EGILS). Paris staging system for primary gastrointestinal lymphoma. Gut. 52:2003;912-913
28. Wotherspoon A.C., Doglioni C., Diss T.C., Pan L., Moschini A., de Boni M., et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa- associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet. 342:1993;575-577
29. Bayerdorffer E., Neubauer A., Rudolph B., Thiede C., Lehn N., Eidt S., et al. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group. Lancet. 345:1995;1591-1594
30. Neubauer A., Thiede C., Morgner A., Alpen B., Ritter M., Neubauer B., et al. Cure of Helicobacter pylori infection and duration of remission of low- grade gastric mucosa-associated lymphoid tissue lymphoma. J Natl Cancer Inst. 89:1997;1350-1355
31. Nobre-Leitao C., Lage P., Cravo M., Cabecadas J., Chaves P., Alberto-Santos A., et al. Treatment of gastric MALT lymphoma by Helicobacter pylori eradication: a study controlled by endoscopic ultrasonography. Am J Gastroenterol. 93:1998;732-736
32. Pinotti G., Zucca E., Roggero E., Pascarella A., Bertoni F., Savio A., et al. Clinical features, treatment and outcome in a series of 93 patients with low-grade gastric MALT lymphoma. Leuk Lymphoma. 26:1997;527-537
33. Roggero E., Zucca E., Pinotti G., Pascarella A., Capella C., Savio A., et al. Eradication of Helicobacter pylori infection in primary low-grade gastric lymphoma of mucosa-associated lymphoid tissue. Ann Intern Med. 122:1995;767-769
34. Savio A., Franzin G., Wotherspoon A.C., Zamboni G., Negrini R., Buffoli F., et al. Diagnosis and posttreatment follow-up of Helicobacter pylori-positive gastric lymphoma of mucosa-associated lymphoid tissue: histology, polymerase chain reaction, or both? Blood. 87:1996;1255-1260
35. Steinbach G., Ford R., Glober G., Sample D., Hagemeister F.B., Lynch P.M., et al. Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial. Ann Intern Med. 131:1999;88-95
36. Montalban C., Santon A., Boixeda D., Redondo C., Alvarez I., Calleja J.L., et al. Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histologic and molecular follow-up. Haematologica. 86:2001;609-617
37. Nakamura S., Matsumoto T., Suekane H., Takeshita M., Hizawa K., Kawasaki M., et al. Predictive value of endoscopic ultrasonography for regression of gastric low grade and high grade MALT lymphomas after eradication of Helicobacter pylori. Gut. 48:2001;454-460
38. Sackmann M., Morgner A., Rudolph B., Neubauer A., Thiede C., Schulz H., et al. Regression of gastric MALT lymphoma after eradication of Helicobacter pylori is predicted by endosonographic staging. MALT Lymphoma Study Group. Gastroenterology. 113:1997;1087-1090
39. Isaacson P.G., Diss T.C., Wotherspoon A.C., Barbazza R., De Boni M., Doglioni C. Long-term follow-up of gastric MALT lymphoma treated by eradication of H. pylori with antibodies. Gastroenterology. 117:1999;750-751
40. Thiede C., Wundisch T., Alpen B., Neubauer B., Morgner A., Schmitz M., et al. Long-term persistence of monoclonal B cells after cure of Helicobacter pylori infection and complete histologic remission in gastric mucosa-associated lymphoid tissue B-cell lymphoma. J Clin Oncol. 19:2001;1600-1609
41. Ye H., Liu H., Raderer M., Chott A., Ruskone-Fourmestraux A., Wotherspoon A., et al. High incidence of t(11;18)(q21;q21) in Helicobacter pylori-negative gastric MALT lymphoma. Blood. 101:2003;2547-2550
42. Liu H., Ye H., Dogan A., Ranaldi R., Hamoudi R.A., Bearzi I., et al. T(11;18)(q21;q21) is associated with advanced mucosa-associated lymphoid tissue lymphoma that expresses nuclear BCL10. Blood. 98:2001;1182-1187
43. Liu H., Ruskone-Fourmestraux A., Lavergne-Slove A., Ye H., Molina T., Bouhnik Y., et al. Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy. Lancet. 357:2001;39-40
44. Liu H., Ye H., Ruskone-Fourmestraux A., De Jong D., Pileri S., Thiede C., et al. T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication. Gastroenterology. 122:2002;1286-1294
45. Hammel P., Haioun C., Chaumette M.T., Gaulard P., Divine M., Reyes F., et al. Efficacy of single-agent chemotherapy in low-grade B-cell mucosa-associated lymphoid tissue lymphoma with prominent gastric expression. J Clin Oncol. 13:1995;2524-2529
46. Durr E.D., Bonner J.A., Strickler J.G., Martenson J.A., Chen M.G., Habermann T.M., et al. Management of stage IE primary gastric lymphoma. Acta Haematol. 94:1995;59-68
47. Fung C.Y., Grossbard M.L., Linggood R.M., Younger J., Flieder A., Harris N.L., et al. Mucosa-associated lymphoid tissue lymphoma of the stomach: long term outcome after local treatment. Cancer. 85:1999;9-17
48. Sano T. Treatment of primary gastric lymphoma: experience in the National Cancer Center Hospital, Tokyo. Recent Results Cancer Res. 156:2000;104-107
49. Vaillant J.C., Ruskone-Fourmestraux A., Aegerter P., Gayet B., Rambaud J.C., Valleur P., et al. Management and long-term results of surgery for localized gastric lymphomas. Am J Surg. 179:2000;216-222
50. Jelic S., Kovcin V., Jovanovic V., Opric M., Milanovic N. Primary gastric non-Hodgkin's lymphoma localized to the gastric wall: no adjuvant treatment following radical surgery. Oncology. 51:1994;270-272
51. Ruskoné-Fourmestraux A., Lavergne A., Delmer A., Rambaud J.C. Lymphomes gastro-intestinaux. 2000;Médecine-Sciences, Flammarion, Paris
52. Tsang R.W., Gospodarowicz M.K., Pintilie M., Bezjak A., Wells W., Hodgson D.C., et al. Stage I and II MALT lymphoma: results of treatment with radiotherapy. Int J Radiat Oncol Biol Phys. 50:2001;1258-1264
53. Ruskone-Fourmestraux A., Lavergne-Slove A., Delmer A. Synopsis: gastrointestinal lymphomas. Gastroenterol Clin Biol. 26:2002;233-241
54. Radaszkiewicz T., Dragosics B., Bauer P. Gastrointestinal malignant lymphomas of the mucosa-associated lymphoid tissue: factors relevant to prognosis. Gastroenterology. 102:1992;1628-1638
55. Raderer M., Valencak J., Osterreicher C., Drach J., Hejna M., Kornek G., et al. Chemotherapy for the treatment of patients with primary high grade gastric B-cell lymphoma of modified Ann Arbor Stages IE and IIE. Cancer. 88:2000;1979-1985
56. Koch P., del Valle F., Berdel W.E., Willich N.A., Reers B., Hiddemann W., et al. Primary gastrointestinal non-Hodgkin's lymphoma: II. Combined surgical and conservative or conservative management only in localized gastric lymphoma-results of the prospective German Multicenter Study GIT NHL 01/92. J Clin Oncol. 19:2001;3874-3883
57. Coiffier B., Lepage E., Briere J., Herbrecht R., Tilly H., Bouabdallah R., et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med. 346:2002;235-242